PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 40 | -93.9% | 0.00% | – |
| Q2 2023 | $1,000 | – | 658 | +439.3% | 0.00% | – |
| Q1 2023 | $0 | – | 122 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 122 | -15.9% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 145 | -76.7% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 622 | -74.1% | 0.00% | – |
| Q1 2022 | $7,000 | -85.4% | 2,401 | -68.8% | 0.00% | – |
| Q4 2021 | $48,000 | -4.0% | 7,704 | +54.0% | 0.00% | – |
| Q3 2021 | $50,000 | +2.0% | 5,004 | +36.8% | 0.00% | – |
| Q2 2021 | $49,000 | +6.5% | 3,659 | +39.7% | 0.00% | – |
| Q1 2021 | $46,000 | +187.5% | 2,620 | +310.7% | 0.00% | – |
| Q4 2020 | $16,000 | – | 638 | +2178.6% | 0.00% | – |
| Q3 2020 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
| Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
| Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
| Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
| Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
| XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
| Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
| GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |